Form EFFECT Lyell Immunopharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 5, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alpaca Secures MAS In-Principle Approval to Launch Brokerage Services in Singapore
- Ninepoint Partners LP Announces Proposed Introduction of a Fixed Administration Fee and Reduced Management Fees on Certain Funds
- Ameren Missouri updates 20-year energy roadmap to maintain and develop cost-effective energy resources to keep grid reliable for customers
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
